Testing effectiveness (Phase 2)Ended earlyNCT02976038
What this trial is testing
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Who this might be right for
Primary Mitochondrial Disease
Stealth BioTherapeutics Inc. 28